Discordance of aldehyde dehydrogenase 1 and estrogen Receptor expression between primary and metastatic focuses of breast cancer

SHAO Jun  PAN Cui-ping  WANG Ming-wei  WU Xin-hong  MA Biao* 

doi:10.3969/j.issn.0529-1356.2013.02.015

Acta Anatomica Sinica ›› 2013, Vol. 44 ›› Issue (2) : 224-228. DOI: 10.3969/j.issn.0529-1356.2013.02.015

Discordance of aldehyde dehydrogenase 1 and estrogen Receptor expression between primary and metastatic focuses of breast cancer

SHAO Jun¹PAN Cui-ping¹ WANG Ming-wei² WU Xin-hong¹ MA Biao ^1* 

Author information +

History +

Abstract

Objective To analyze the difference of aldehyde dehydrogenase 1(ALDH1) and estrogen receptor (ER) expression between primary and corresponding metastatic focuses of breast cancer. Methods A total of 87 female patients diagnosed with metastatic breast cancer were included in this study. Immunohistochemistry (IHC) was used to detect the expression of ALDH1 and ER between primary and metastatic sites. Integrated absorbance (IA) of stained sections was measured by Image-Pro Plus 6.0 (IPP 6.0)，and then the statistical analysis was done. Results The incidences of ALDH1 and ER expression among the primary tumor were 28.7%(25 cases) and 56.3% (49 cases), while ascending to 43.7% and declined to 32.2% in corresponding metastatic breast cancer, which were statistically significant respectively (P <0.05 and P <0.01). Statistical analysis results of IA showed that ALDH1 expression in metastatic focuses was obviously higher than that in the corresponding primary tumor, while ER expression was significantly lower. Conclusion The frequencies of ALDH1 positive expression and ER negative expression were more frequently observed in metastatic focuses than in primary breast cancer.

Key words

Breast cancer / Metastasis / Stem cell / Aldehyde dehydrogenase 1 / Estrogen receptor / Immunohistochemistry / Human

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

SHAO Jun PAN Cui-ping WANG Ming-wei WU Xin-hong MA Biao* . Discordance of aldehyde dehydrogenase 1 and estrogen Receptor expression between primary and metastatic focuses of breast cancer[J]. Acta Anatomica Sinica. 2013, 44(2): 224-228 https://doi.org/10.3969/j.issn.0529-1356.2013.02.015

References

［1］Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells［J］. Nature, 2001,414 (6859):105-111.

［2］Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells［J］. Proc Natl Acad Sci USA,

2003,100(7):3983-3988.

［3］Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome［J］. Stem Cells, 2007,1(5):555-567.

［4］Ohi Y, Umekita Y, Yoshioka T, et al. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer［J］. Histopathology, 2011,59(4):776-780.

［5］Franco A, Col N, Chlebowski RT. Discordance in estrogen (ER) and progestin receptor (PR) status between primary metastatic breast cancer: a meta-analysis［J］. J Clin Oncol, 2004, 22(14S): 539.

［6］Gong Y, Booser DJ, Sneige N. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma［J］. Cancer, 2005,103(9): 1763-1769.

［7］ Shao J, Pan CP, Ma B. The signal transduction of breast stem cells and breast cancer［J］. Tumor, 2007, 27(9):760-762.(in Chinese)

邵军, 潘翠萍, 马彪. 乳腺干细胞的信号转导与乳腺癌［J］. 肿瘤, 2007，27(9)：760-762.

［8］Charafe-Jauffret E, Ginestier C, Iovino F, et al. Aldehyde dehydrogenase1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer［J］. Clin Cancer Res, 2010, 16(1): 45-55.

［9］ Nalwoga H, Arnes JB, Wabinga H, et al. Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumors in African breast cancer［J］. Br J Cancer, 2010,102(2):369-375.

［10］Deng S, Yang X, Lassus H, et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers［J］. PLoS One, 2010,5(4):e10277.

［11］Morimoto K, Kim SJ, Tanei T, et al. Stem cell marker aldehyde

dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression［J］. Cancer Sci, 2009,100(6):1062-1068.

［12］ De Brot M, Rocha RM, Soares FA, et al. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers［J］. Pathology, 2012,44(4):303-312.